Miami, FL – March 17, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on USA Equities Corp (OTC Pink: USAQ).

USA Equities Corp. (USAQ). On December 20, 2019 USA Equities Corp entered into and consummated a share exchange with the former stockholders of Medical Practice Income (MPI) a Florida corporation. As a result of the Share Exchange, MPI became our wholly-owned-subsidiary. We currently are focused on the development of value-based healthcare solutions, clinical informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. 

Average daily volume for PURE 1 thousand shares. Today’s news has caused the volume to increase to over 12 thousand shares in the morning hours of trading.

USA Equities Corp Press Release:

USA Equities Corp Launches its 2020 Corporate Presentation to Investors — USA Equities Corp received IRB Approval for its Novel Allergy Patient Education app study to combat the allergy suffering misery of millions of Americans, especially during allergy seasons.

West Palm Beach, FL, March 17, 2020 (GLOBE NEWSWIRE) — USA Equities Corp (OTC Markets: USAQ), a Company focused on the development of value-based healthcare solutions, informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine.

“This has been a transformative period for USA Equities Corp with our share exchange with the former stockholders of Medical Practice Income (MPI), and recent announcement of the formation of our initial Advisory Board of Senior Medical, Scientific and Information Scientists. The Company is now well positioned to deliver on its stated mission, to enhance the quality of life of individuals and populations through, evidence-based, digital medical assessments, and innovative preventive health programs” Troy Grogan, President and CEO.

Business Update

On December 20, 2019 USA Equities Corp entered into and consummated a share exchange with the former stockholders of Medical Practice Income (MPI) a Florida corporation.

On March 13, 2020, we announced the appointment of our initial advisory board of highly competent, credentialed and experienced Medical and Scientific Advisors, see bios at www.medicalpracticeincome.com/about-usaq

The Medical Practice Income 2020 Corporation Presentation can be found at the Company’s website www.MedicalPracticeIncome.com/Investors

The Company’s Principle objective

Develop digital tools and approaches, providing more granular, timely and specific clinical decision-making information to address today’s now younger, obese, diabetic, cardiovascular and chronic disease population.

Research and Development Update

In early March 2020, MPI received IRB approval from Larkin Community Hospital to begin research of its novel Patient Allergy IQ Study.

This study aims to evaluate responder’s allergy knowledge and beliefs relating to common allergen triggers and environmental control strategies. We will compare medical doctors and other health professionals to non-health professional answers to a simple multiple-choice and true-false Allergy IQ Quiz. Results of the study will assist in developing reimbursable digital medicine learning resources targeted at the patients identified knowledge gaps.

Key points

— Allergy is currently the 6th leading chronic disease in the US(1) — Allergy affects over 50M Americans(1) — Allergies and Asthma cost the economy $Billions each year(1) — There is a published shortage of Board-certified Allergy specialists to treat the number of allergy sufferers(2) — There are identified gaps in primary care provider (PCP) and non-allergy board certified specialist training/ knowledge relating to evidence based allergic disease management(3) — Allergen triggers and knowledge of environmental control strategies for allergic disease can be confusing(4) — Many allergy sufferers self-medicate using OTC medications without consulting their medical professional’s advice(5) — Evidence based prevention strategies currently exist for better controlling and/or managing allergies(4)

MPI advisory board member and Principal Investigator, Dr Marcos Sanchez-Gonzales says “Physicians require new and easy to use preventive and chronic care management tools that engage and track patients, especially while they’re not in front of their physician. For example, MPI has completed the initial enrollment of participants for the health literacy allergy study that will provide allergy suffering patients with an easy to use digital allergy IQ quiz. Based on proprietary algorithm that is being use in this study, the patients answer to the quiz will enable the their health care provider to pin point the health education required for that specific patient to better control their allergy suffering.”

Results of this new and exciting study are expected to be released in the Fourth Quarter 2020.

About USA Equities Corp

USA Equities Corp. (USAQ). On December 20, 2019 USA Equities Corp entered into and consummated a share exchange with the former stockholders of Medical Practice Income (MPI) a Florida corporation. As a result of the Share Exchange, MPI became our wholly-owned-subsidiary. We currently are focused on the development of value-based healthcare solutions, clinical informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. The Company’s intellectual properties, products and information service portfolio is directed towards prevention, early detection, management and reversal of cardiometabolic and other chronic diseases. Our principle objectives are to develop proprietary software tools, devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address todays now younger, obese, diabetic and cardiovascular disease population and is located in West Palm Beach, Florida. For more information, visit www.MedicalPracticeIncome.com.

Forward-Looking Statements

This press release contains forward-looking statements which are identified by words such as ‘may’, ‘could’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’, or ‘intends’ and other similar words that involve risks and uncertainties. These statements have not been based solely on historical facts but on USA Equities Corp current expectations about future events and results. You should consider that as such statements relate to future matters, they are subject to various inherent risks, uncertainties and assumptions that could cause actual results or events to differ materially from expectations described in the forward-looking statement. Various important factors could cause actual results or events to differ materially from the forward-looking statements that USA Equities Corp makes, including, but not limited to, the risk that software development and studies may be delayed and may not have satisfactory outcomes, the risk that costs required to continue our Software as a Medical Device (SaMD) or to expand our operations will be higher than anticipated and other risks described in the “Risk Factors” section of our Annual Report on Form 10-K filed by USA Equities Corp with the SEC on February 21, 2020. Except where required by law, USA Equities Corp. has no intention to update or revise forward looking statements, or to publish prospective financial information in the future, regardless of whether new information, future events or any other factors affect the information contained in this presentation. None of USA Equities Corp Directors, Consultants, or any other person named with their consent in this presentation can assure you that any forward-looking statement or result expressed or implied by any forward-looking statement will be achieved.

References

1. American College of Allergy, Asthma, and Immunology. Allergy facts. https://acaai.org/news/facts-statistics/allergies. Accessed February 20, 2020. ————————————————————————– 2. American College of Allergy, Asthma and Immunology. Graduate Medical Education and Workforce Issues in Allergy and Immunology. 2008. 3. Smith H, Wade J, Frew A. What proportion of adult allergy referrals to secondary care could be dealt with in primary care by a GP with special interest? Clin Transl Allergy. 2016;6:3. 4. https://acaai.org/allergies/allergy-treatment/environmental-tri gger-avoidance Accessed February 20, 2020. ————————————————————————– 5. Tan et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. Asthma Research and Practice (2017) 3:8 DOI 10.1186/s40733-017-0036-z

Investor & Media Contact:

Elizabeth Magdaleno

Medical Practice Income, Inc.

(929) 374-6503

Admin@medicalpracticeincome.com 

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, http://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Add a Comment to this Post

comments